- New
21.6mg Numelvi Tablets for Dogs - Per Tablet
965303
21.6mg Numelvi Tablets are a prescription treatment for dogs with itching linked to allergic skin disease. Numelvi Tablets contain atinvicitinib, a selective Janus kinase 1, or JAK1, inhibitor used to manage pruritus associated with allergic dermatitis and the clinical signs of atopic dermatitis. For many dogs, itch can become a relentless cycle of scratching, licking, chewing and rubbing that affects sleep, comfort, skin health and day-to-day behaviour.
21.6mg Numelvi is designed to help interrupt that cycle in a targeted way, so dogs can feel more settled while damaged skin has a better chance to recover.
Allergic dermatitis is a broad clinical term for inflammation of the skin triggered by an allergic response. In dogs, common causes include flea allergy dermatitis, reactions to environmental allergens such as pollens or house dust mites, contact reactions and food allergy. Atopic dermatitis is one of the most common allergic skin disorders seen in practice and usually has a chronic, relapsing pattern. Dogs with atopic dermatitis often have a genetically influenced skin barrier problem as well as an exaggerated immune response to everyday allergens. Signs can include persistent pruritus, erythema, recurrent ear irritation, paw licking, rubbing around the face, thinning coat, excoriations, saliva staining, lichenification and secondary bacterial or yeast overgrowth.
Some dogs seem restless or irritable simply because they cannot stop itching, while others develop sore hotspots, thickened skin or recurrent otitis externa. Sleep disruption, constant licking and repeated skin trauma can also have an effect on quality of life. 21.6mg Numelvi Tablets do not cure the underlying allergy, but they can be very helpful in controlling the itch and inflammatory signalling that make these conditions so distressing.
VETERINARY PRESCRIPTION REQUIRED
More Information
Description
21.6mg Numelvi Tablets act mainly on JAK1-dependent pathways, which are involved in the action of several cytokines linked with pruritus, allergy and inflammation. When these chemical signals are active, a dog’s skin and nervous system receive repeated messages that drive itching, redness and irritation. By reducing that signal transmission, Numelvi Tablets help calm the itch response rather than simply masking it. This matters in allergic dermatitis and atopic dermatitis because once a dog starts scratching, the skin barrier can break down further, allowing more inflammation, self-trauma and secondary infection.
For dogs with allergic dermatitis, a proper diagnosis remains important even when itch control is the immediate priority. A veterinary surgeon may need to rule out or treat complicating factors such as fleas, Demodex mites, bacterial pyoderma, Malassezia dermatitis, food reactions or contact irritants. Atopic dermatitis can also wax and wane with season, environment and skin flare-ups, so treatment often needs to be tailored to the individual dog. 21.6mg Numelvi is available as scored tablets, which means they can be divided into equal halves when the prescribed dose requires it. The 21.6 mg strength is generally used for dogs needing this tablet size as part of their weight-based dosing schedule, and the dose should always follow the prescribing vet’s instructions.
Numelvi Tablets are given by mouth once daily, usually at or around feeding time. This routine can make ongoing treatment easier for both dog and owner. The tablets are white to off-white, oblong and scored, and some dogs manage them readily when hidden in food if this is appropriate for their prescription plan. As with any prescription medicine, monitoring matters. Your vet may review how well 21.6mg Numelvi Tablets are controlling pruritus, whether the skin is healing, and whether there are signs that another condition is still active underneath the itch. The more commonly reported adverse effects are gastrointestinal upset, reduced appetite or lethargy, so owners should speak to their vet promptly if vomiting, diarrhoea, marked tiredness, loss of appetite or worsening skin problems develop. A review is also sensible if the itch returns between appointments, because flare-ups can signal infection, flea exposure or another trigger that needs separate treatment.
21.6mg Numelvi Tablets often form one part of a wider management plan rather than the whole answer on their own. Dogs with atopic dermatitis may also benefit from regular parasite control, medicated or soothing shampoos, topical skin barrier support, ear care, diet trials where indicated, and treatment for secondary infection when present. That combined approach is often the most reliable way to reduce flare-ups and keep the skin comfortable over time. 21.6mg Numelvi Tablets can be especially useful when the main problem is persistent itch that keeps the inflammatory cycle going, because better itch control can mean less chewing at the feet, less rubbing at the face, fewer excoriations and a calmer dog overall. Some dogs need seasonal support, while others need longer courses based on veterinary assessment of benefit and risk. When used under veterinary direction, 21.6mg Numelvi Tablets offer a focused option for dogs living with allergic dermatitis or atopic dermatitis, especially when consistent, once-daily itch management is an important part of care.
What are 21.6mg Numelvi Tablets used for in dogs?
Numelvi Tablets are used to treat pruritus associated with allergic dermatitis and the clinical signs of atopic dermatitis in dogs. They are prescribed when a dog’s itching, licking, chewing or rubbing is being driven by allergy-related skin inflammation and needs targeted control.
How do Numelvi Tablets work?
21.6mg Numelvi Tablets contain atinvicitinib, a selective JAK1 inhibitor. This means they reduce signalling from cytokines involved in itch, allergy and inflammation. By calming those pathways, the tablets help lower the urge to scratch and support better skin comfort while your vet manages the underlying cause.
Are Numelvi Tablets a steroid?
No. Numelvi Tablets are not a corticosteroid. They work through selective JAK1 inhibition rather than steroid activity. That makes them a different type of itch-control medicine, used under veterinary guidance for dogs with allergic dermatitis or atopic dermatitis that need targeted management.
Can 21.6mg Numelvi Tablets help dogs with atopic dermatitis?
Yes. Numelvi Tablets are indicated for the clinical manifestations associated with atopic dermatitis in dogs, including pruritus. They can be helpful for dogs with chronic, allergy-driven skin disease where itching, redness and self-trauma are making flare-ups harder to control.
What side effects can occur with 21.6mg Numelvi Tablets?
As with many prescription medicines, some dogs may experience side effects. The more commonly reported ones include vomiting, diarrhoea, lethargy or reduced appetite. If your dog seems unwell, the itch worsens, or new skin problems appear, contact your vet promptly for further advice.
Are Numelvi Tablets suitable for puppies?
Numelvi Tablets have not been investigated in dogs under six months of age or weighing less than 3 kg. Puppies with itch should always be assessed carefully, because parasites, infection and food reactions can look similar to allergy and may need a different approach.
You may also like
